Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.
A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
| Title
|
Date published
|
|
|
|
1.17 BONUS! Interpretation of Cancer Clinical Trials
|
2018-10-22
|
|
|
|
1.16 BONUS! Crowdsourcing Data Analysis and Medical Reversal: Why 40% of What We Do is Wrong
|
2018-10-17
|
|
|
|
1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare
|
2018-10-16
|
|
|
|
1.14 BONUS! Immunotherapy in Desperation and the Pennington Lecture: Myths of Medicine and Marketing
|
2018-10-12
|
|
|
|
1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu
|
2018-10-08
|
|
|
|
1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology
|
2018-10-03
|
|
|
|
1.11 Peanut Gallery, Research Parasites, Appendectomies, HRQoL and PFS, Dr. Bishal Gyawali
|
2018-10-02
|
|
|
|
1.10 Criticism via Twitter, PACIFIC, PCI for CAD, and Dr. Rebecca Cooney of The Lancet
|
2018-09-25
|
|
|
|
1.09 Response Rate in Phase I trials, JACOB, and MI, Stroke, and Metastasis as Hard Endpoints
|
2018-09-20
|
|
|
|
1.08 Hyperprolific authors, NCCN with Jeff Wagner, and Dr. Renee Dversdal on Ultrasounds
|
2018-09-14
|
|
|
|
1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola
|
2018-09-11
|
|
|
|
1.06 RELEVANCE, Jenny Gill, and Dr. Catherine Livingston of the Oregon Health Authority
|
2018-09-07
|
|
|
|
1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity
|
2018-09-05
|
|
|
|
1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser
|
2018-08-30
|
|
|
|
1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross
|
2018-08-21
|
|
|
|
1.02: HemOnc Fellowship and Hype in Cancer Medicine with Dr. Jeremy Cetnar
|
2018-08-16
|
|
|
|
1.01: Introduction and Dr. Adam Obley
|
2018-08-14
|
|
|
